Adage Capital Partners
PMVP icon

Adage Capital Partners’s PMV Pharmaceuticals PMVP Stock Holding History

Adage Capital Partners’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Buy
+1,860,000
New +$2.37M ﹤0.01% 830
2021
Q4 		– Sell
-53,000
Closed -$1.58M – 1086
2021
Q3 		$1.58M Hold
53,000
– – ﹤0.01% 902
2021
Q2 		$1.81M Sell
53,000
-25,000
-32% -$835K ﹤0.01% 881
2021
Q1 		$2.56M Buy
+78,000
New +$3.07M 0.01% 846

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners's PMVP Position: Q1 2026 in Review

Adage Capital Partners opened a new position in PMV Pharmaceuticals (PMVP) in Q1 2026: 1,860,000 shares worth $2.31M. The stake represents ﹤0.01% of the portfolio and ranks #830 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in PMVP as recently as Q3 2021.

Adage Capital Partners first reported a position in PMVP in Q1 2021 and has held it in 4 quarters since. The position peaked at $2.56M in Q1 2021. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Adage Capital Partners held 1,860,000 shares of PMV Pharmaceuticals worth $2.31M as of Q1 2026.
  • PMV Pharmaceuticals was a new Adage Capital Partners position in Q1 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Adage Capital Partners's portfolio in Q1 2026, its #830 holding.
  • Adage Capital Partners first reported a position in PMV Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • Adage Capital Partners's PMV Pharmaceuticals position peaked at $2.56M in Q1 2021.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.